RenovoRx Inc. (RNXT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for RenovoRx Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.43
+2.52% today
Market cap
$63M
Overall quality
—
Kronos AI 30-day
+5.1%
5 of 8 simulated paths end higher
RenovoRx Inc. (RNXT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $63M. It trades at $1.43, up 2.52% today. 4 analysts' average target of $7.13 implies +398.6% from today's price. Kronos AI's 30-day forecast is +5.1% (5 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $7.13 |
| Low – high | $3.00 – $14.50 |
| Analysts | 4 |
| Upside to average | +398.6% |
Kronos AI 30-day forecast
| Expected close | $1.46 (+5.1%) |
| Likely range | −14.2% … +15.5% |
| As of | 2026-10-27 |
5 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.